HEADER TRANSFERASE/CELL CYCLE 02-OCT-12 4BCO TITLE STRUCTURE OF CDK2 IN COMPLEX WITH CYCLIN A AND A 2-AMINO-4-HETEROARYL- TITLE 2 PYRIMIDINE INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: CYCLIN-DEPENDENT KINASE 2; COMPND 3 CHAIN: A, C; COMPND 4 SYNONYM: CELL DIVISION PROTEIN KINASE 2, P33 PROTEIN KINASE; COMPND 5 EC: 2.7.11.22; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: CYCLIN-A2; COMPND 9 CHAIN: B, D; COMPND 10 SYNONYM: CYCLIN-A; COMPND 11 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 MOL_ID: 2; SOURCE 8 ORGANISM_SCIENTIFIC: BOS TAURUS; SOURCE 9 ORGANISM_COMMON: BOVINE; SOURCE 10 ORGANISM_TAXID: 9913; SOURCE 11 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 12 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS TRANSFERASE-CELL CYCLE COMPLEX, CDK-CYCLIN COMPLEX, CYCLIN-INHIBITOR, KEYWDS 2 STRUCTURE-BASED DRUG DESIGN EXPDTA X-RAY DIFFRACTION AUTHOR A.J.HOLE,S.BAUMLI,S.WANG,J.A.ENDICOTT,M.E.M.NOBLE REVDAT 3 16-OCT-24 4BCO 1 REMARK LINK REVDAT 2 27-FEB-13 4BCO 1 JRNL REVDAT 1 09-JAN-13 4BCO 0 JRNL AUTH A.J.HOLE,S.BAUMLI,H.SHAO,S.SHI,C.PEPPER,P.M.FISCHER,S.WANG, JRNL AUTH 2 J.A.ENDICOTT,M.E.M.NOBLE JRNL TITL COMPARATIVE STRUCTURAL AND FUNCTIONAL STUDIES OF 4-(THIAZOL- JRNL TITL 2 5-YL)-2-(PHENYLAMINO)PYRIMIDINE-5-CARBONITRILE CDK9 JRNL TITL 3 INHIBITORS SUGGEST THE BASIS FOR ISOTYPE SELECTIVITY. JRNL REF J.MED.CHEM. V. 56 660 2013 JRNL REFN ISSN 0022-2623 JRNL PMID 23252711 JRNL DOI 10.1021/JM301495V REMARK 2 REMARK 2 RESOLUTION. 2.05 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.05 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 49.60 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 3 NUMBER OF REFLECTIONS : 91969 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.191 REMARK 3 R VALUE (WORKING SET) : 0.189 REMARK 3 FREE R VALUE : 0.226 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 4595 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 49.6138 - 6.3655 0.97 3082 162 0.1856 0.1985 REMARK 3 2 6.3655 - 5.0541 0.98 3000 144 0.1932 0.2649 REMARK 3 3 5.0541 - 4.4157 0.99 2974 161 0.1525 0.1905 REMARK 3 4 4.4157 - 4.0122 0.99 2964 157 0.1568 0.1948 REMARK 3 5 4.0122 - 3.7247 0.98 2888 170 0.1675 0.1839 REMARK 3 6 3.7247 - 3.5051 0.97 2877 145 0.1708 0.2097 REMARK 3 7 3.5051 - 3.3296 0.99 2899 175 0.1749 0.2054 REMARK 3 8 3.3296 - 3.1847 0.99 2941 139 0.1821 0.1958 REMARK 3 9 3.1847 - 3.0621 1.00 2926 160 0.1880 0.2274 REMARK 3 10 3.0621 - 2.9565 0.99 2902 146 0.1893 0.2349 REMARK 3 11 2.9565 - 2.8641 0.97 2888 159 0.2080 0.2339 REMARK 3 12 2.8641 - 2.7822 0.99 2890 130 0.2057 0.2539 REMARK 3 13 2.7822 - 2.7090 0.99 2929 159 0.2031 0.2370 REMARK 3 14 2.7090 - 2.6429 0.99 2872 154 0.1935 0.2369 REMARK 3 15 2.6429 - 2.5828 0.99 2959 144 0.1888 0.2108 REMARK 3 16 2.5828 - 2.5278 1.00 2865 184 0.1960 0.2156 REMARK 3 17 2.5278 - 2.4773 1.00 2911 143 0.2079 0.2630 REMARK 3 18 2.4773 - 2.4305 1.00 2911 162 0.2193 0.3042 REMARK 3 19 2.4305 - 2.3871 0.99 2868 148 0.2210 0.2653 REMARK 3 20 2.3871 - 2.3467 0.98 2880 136 0.2171 0.2675 REMARK 3 21 2.3467 - 2.3088 0.99 2876 174 0.2076 0.2714 REMARK 3 22 2.3088 - 2.2733 1.00 2945 129 0.2091 0.2342 REMARK 3 23 2.2733 - 2.2398 0.99 2831 169 0.2173 0.2741 REMARK 3 24 2.2398 - 2.2083 1.00 2965 144 0.2227 0.2972 REMARK 3 25 2.2083 - 2.1785 1.00 2888 135 0.2151 0.2345 REMARK 3 26 2.1785 - 2.1502 1.00 2900 145 0.2210 0.3085 REMARK 3 27 2.1502 - 2.1233 1.00 2903 145 0.2329 0.2629 REMARK 3 28 2.1233 - 2.0977 1.00 2930 152 0.2428 0.2930 REMARK 3 29 2.0977 - 2.0733 1.00 2901 149 0.2431 0.2987 REMARK 3 30 2.0733 - 2.0500 0.98 2809 175 0.2492 0.2848 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.20 REMARK 3 SHRINKAGE RADIUS : 0.95 REMARK 3 K_SOL : 0.39 REMARK 3 B_SOL : 44.55 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.640 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 21.080 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 32.61 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.76620 REMARK 3 B22 (A**2) : -0.06470 REMARK 3 B33 (A**2) : 0.83090 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.005 9050 REMARK 3 ANGLE : 0.902 12282 REMARK 3 CHIRALITY : 0.061 1388 REMARK 3 PLANARITY : 0.004 1534 REMARK 3 DIHEDRAL : 14.168 3386 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 8 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: CHAIN A AND (RESSEQ 1:85) REMARK 3 ORIGIN FOR THE GROUP (A): -10.5758 13.3096 -23.8003 REMARK 3 T TENSOR REMARK 3 T11: 0.2267 T22: 0.2697 REMARK 3 T33: 0.2648 T12: 0.0307 REMARK 3 T13: 0.0230 T23: -0.0355 REMARK 3 L TENSOR REMARK 3 L11: 1.5874 L22: 2.0853 REMARK 3 L33: 2.7631 L12: 0.1657 REMARK 3 L13: 1.0085 L23: -1.0155 REMARK 3 S TENSOR REMARK 3 S11: 0.1154 S12: 0.2671 S13: -0.2469 REMARK 3 S21: -0.3076 S22: -0.1502 S23: -0.3229 REMARK 3 S31: 0.3443 S32: 0.5067 S33: 0.0281 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: CHAIN A AND (RESSEQ 86:298) REMARK 3 ORIGIN FOR THE GROUP (A): -5.4534 31.0799 -4.1780 REMARK 3 T TENSOR REMARK 3 T11: 0.1396 T22: 0.2112 REMARK 3 T33: 0.2154 T12: 0.0026 REMARK 3 T13: 0.0259 T23: -0.0457 REMARK 3 L TENSOR REMARK 3 L11: 1.7842 L22: 0.7660 REMARK 3 L33: 1.0665 L12: 0.1904 REMARK 3 L13: 0.9682 L23: 0.0018 REMARK 3 S TENSOR REMARK 3 S11: -0.0015 S12: -0.1087 S13: 0.1820 REMARK 3 S21: 0.0164 S22: -0.0031 S23: -0.0670 REMARK 3 S31: -0.0485 S32: 0.0697 S33: 0.0164 REMARK 3 TLS GROUP : 3 REMARK 3 SELECTION: CHAIN B REMARK 3 ORIGIN FOR THE GROUP (A): -22.0153 -0.3932 3.5941 REMARK 3 T TENSOR REMARK 3 T11: 0.1770 T22: 0.1943 REMARK 3 T33: 0.1590 T12: -0.0102 REMARK 3 T13: -0.0386 T23: 0.0367 REMARK 3 L TENSOR REMARK 3 L11: 1.5180 L22: 1.7044 REMARK 3 L33: 1.7085 L12: -0.6213 REMARK 3 L13: -0.6254 L23: 0.3756 REMARK 3 S TENSOR REMARK 3 S11: -0.0695 S12: -0.2279 S13: -0.1054 REMARK 3 S21: 0.1347 S22: 0.0984 S23: 0.0383 REMARK 3 S31: 0.2495 S32: 0.0315 S33: -0.0375 REMARK 3 TLS GROUP : 4 REMARK 3 SELECTION: CHAIN C AND (RESSEQ 1:85) REMARK 3 ORIGIN FOR THE GROUP (A): -28.3432 -9.3700 -30.6746 REMARK 3 T TENSOR REMARK 3 T11: 0.3789 T22: 0.2819 REMARK 3 T33: 0.2747 T12: 0.0075 REMARK 3 T13: -0.0168 T23: -0.0573 REMARK 3 L TENSOR REMARK 3 L11: 1.2945 L22: 2.0480 REMARK 3 L33: 1.6454 L12: -0.1215 REMARK 3 L13: 0.8956 L23: -1.5021 REMARK 3 S TENSOR REMARK 3 S11: 0.2710 S12: 0.2399 S13: -0.0705 REMARK 3 S21: -0.1289 S22: -0.1476 S23: -0.0567 REMARK 3 S31: 0.2784 S32: 0.2594 S33: -0.1204 REMARK 3 TLS GROUP : 5 REMARK 3 SELECTION: CHAIN C AND (RESSEQ 86:298) REMARK 3 ORIGIN FOR THE GROUP (A): -52.3670 -16.9444 -31.7441 REMARK 3 T TENSOR REMARK 3 T11: 0.2974 T22: 0.3398 REMARK 3 T33: 0.2717 T12: -0.0992 REMARK 3 T13: 0.0478 T23: -0.0582 REMARK 3 L TENSOR REMARK 3 L11: 1.3538 L22: 2.4140 REMARK 3 L33: 1.6378 L12: -0.0401 REMARK 3 L13: 0.3049 L23: 0.1004 REMARK 3 S TENSOR REMARK 3 S11: 0.0861 S12: 0.0267 S13: -0.1624 REMARK 3 S21: 0.1422 S22: -0.0714 S23: 0.3677 REMARK 3 S31: 0.2885 S32: -0.3942 S33: -0.0021 REMARK 3 TLS GROUP : 6 REMARK 3 SELECTION: CHAIN D REMARK 3 ORIGIN FOR THE GROUP (A): -45.0284 18.7255 -34.8806 REMARK 3 T TENSOR REMARK 3 T11: 0.2821 T22: 0.2182 REMARK 3 T33: 0.3530 T12: 0.0923 REMARK 3 T13: 0.0515 T23: -0.0107 REMARK 3 L TENSOR REMARK 3 L11: 1.9322 L22: 1.9124 REMARK 3 L33: 1.4614 L12: 0.7387 REMARK 3 L13: -0.1429 L23: -0.0959 REMARK 3 S TENSOR REMARK 3 S11: 0.0133 S12: 0.0129 S13: 0.3956 REMARK 3 S21: 0.2064 S22: 0.0080 S23: 0.5594 REMARK 3 S31: -0.1538 S32: -0.2832 S33: -0.0043 REMARK 3 TLS GROUP : 7 REMARK 3 SELECTION: CHAIN A (RESSEQ 1299) REMARK 3 ORIGIN FOR THE GROUP (A): -6.1615 23.1920 -24.5163 REMARK 3 T TENSOR REMARK 3 T11: 0.3564 T22: 0.2615 REMARK 3 T33: 0.2867 T12: 0.0410 REMARK 3 T13: 0.0180 T23: -0.0602 REMARK 3 L TENSOR REMARK 3 L11: 2.0036 L22: 9.2018 REMARK 3 L33: 2.0897 L12: 1.1472 REMARK 3 L13: 3.2706 L23: -0.5678 REMARK 3 S TENSOR REMARK 3 S11: -0.2619 S12: 0.4381 S13: -0.1002 REMARK 3 S21: -1.0921 S22: -0.0963 S23: -0.1211 REMARK 3 S31: -0.1197 S32: 0.2353 S33: 0.3637 REMARK 3 TLS GROUP : 8 REMARK 3 SELECTION: CHAIN C (RESSEQ 1298) REMARK 3 ORIGIN FOR THE GROUP (A): -32.4647 -19.4808 -30.2711 REMARK 3 T TENSOR REMARK 3 T11: 0.5134 T22: 0.8134 REMARK 3 T33: 0.3175 T12: -0.1591 REMARK 3 T13: -0.0252 T23: -0.0169 REMARK 3 L TENSOR REMARK 3 L11: 5.6057 L22: 5.1814 REMARK 3 L33: 7.7081 L12: 2.1148 REMARK 3 L13: 0.3328 L23: 1.3086 REMARK 3 S TENSOR REMARK 3 S11: -0.1383 S12: 0.1352 S13: -0.3754 REMARK 3 S21: -0.2981 S22: -0.0282 S23: -0.3578 REMARK 3 S31: -0.1976 S32: 0.2996 S33: 0.1724 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4BCO COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 02-OCT-12. REMARK 100 THE DEPOSITION ID IS D_1290054254. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I03 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9763 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 92057 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.580 REMARK 200 RESOLUTION RANGE LOW (A) : 52.360 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 200 DATA REDUNDANCY : 3.220 REMARK 200 R MERGE (I) : 0.08000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.1600 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.05 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.16 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.4 REMARK 200 DATA REDUNDANCY IN SHELL : 3.29 REMARK 200 R MERGE FOR SHELL (I) : 0.54000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.410 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 58.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.90 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: COCRYSTALS WERE GROWN IN 1-1.25M REMARK 280 AMMONIUM SULFATE, 0.5-0.9M KCL, 100MM HEPES, PH 7.0, 5MM DTT AND REMARK 280 IN THE PRESENCE OF COMPOUND. REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 36.95100 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 74.19100 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 66.90650 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 74.19100 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 36.95100 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 66.90650 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3720 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 23090 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -31.9 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3860 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 21910 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -32.5 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -1 REMARK 465 SER B 171 REMARK 465 VAL B 172 REMARK 465 ASN B 173 REMARK 465 GLU B 174 REMARK 465 GLY C -1 REMARK 465 PRO C 222 REMARK 465 ASP C 223 REMARK 465 GLU C 224 REMARK 465 VAL C 225 REMARK 465 VAL C 226 REMARK 465 TRP C 227 REMARK 465 PRO C 228 REMARK 465 GLY C 229 REMARK 465 VAL C 230 REMARK 465 THR C 231 REMARK 465 SER C 232 REMARK 465 MET C 233 REMARK 465 PRO C 234 REMARK 465 ASP C 235 REMARK 465 TYR C 236 REMARK 465 LYS C 237 REMARK 465 PRO C 238 REMARK 465 SER C 239 REMARK 465 PHE C 240 REMARK 465 PRO C 241 REMARK 465 LYS C 242 REMARK 465 TRP C 243 REMARK 465 ALA C 244 REMARK 465 ARG C 245 REMARK 465 GLN C 246 REMARK 465 ASP C 247 REMARK 465 PHE C 248 REMARK 465 ARG C 297 REMARK 465 LEU C 298 REMARK 465 SER D 171 REMARK 465 VAL D 172 REMARK 465 ASN D 173 REMARK 465 GLU D 174 REMARK 465 VAL D 175 REMARK 465 PRO D 176 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ALA B 357 CB REMARK 470 ALA D 357 CB REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OH TYR C 15 OE1 GLU C 51 1.97 REMARK 500 O GLN D 203 O HOH D 2022 2.14 REMARK 500 O HOH B 2030 O HOH B 2031 2.17 REMARK 500 O HOH A 2182 O HOH B 2017 2.18 REMARK 500 O HOH D 2006 O HOH D 2048 2.19 REMARK 500 O HOH B 2066 O HOH B 2067 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 41 -53.16 89.56 REMARK 500 GLU A 73 -67.34 -29.64 REMARK 500 ASP A 127 42.35 -154.02 REMARK 500 ASP A 145 82.69 56.93 REMARK 500 VAL A 164 126.90 75.41 REMARK 500 SER A 181 -148.93 -144.97 REMARK 500 THR A 290 -168.98 -128.37 REMARK 500 TYR B 178 -1.00 72.15 REMARK 500 TRP B 372 113.02 -29.37 REMARK 500 THR C 41 -77.36 -129.01 REMARK 500 ASP C 127 39.17 -146.45 REMARK 500 ASP C 145 82.31 55.78 REMARK 500 PHE C 146 30.30 -98.44 REMARK 500 VAL C 164 127.33 71.04 REMARK 500 SER C 181 -148.23 -155.09 REMARK 500 TYR D 178 -3.52 68.08 REMARK 500 TRP D 372 105.90 -24.03 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A2066 DISTANCE = 5.82 ANGSTROMS REMARK 525 HOH B2015 DISTANCE = 6.63 ANGSTROMS REMARK 525 HOH C2004 DISTANCE = 5.89 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE T6Q A 1299 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE T6Q C 1298 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SGM B 1433 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SGM B 1434 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SGM D 1433 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SGM D 1434 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 1435 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 D 1435 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4BCF RELATED DB: PDB REMARK 900 STRUCTURE OF CDK9 IN COMPLEX WITH CYCLIN T AND A 2 -AMINO-4- REMARK 900 HETEROARYL-PYRIMIDINE INHIBITOR REMARK 900 RELATED ID: 4BCG RELATED DB: PDB REMARK 900 STRUCTURE OF CDK9 IN COMPLEX WITH CYCLIN T AND A 2 -AMINO-4- REMARK 900 HETEROARYL-PYRIMIDINE INHIBITOR REMARK 900 RELATED ID: 4BCH RELATED DB: PDB REMARK 900 STRUCTURE OF CDK9 IN COMPLEX WITH CYCLIN T AND A 2 -AMINO-4- REMARK 900 HETEROARYL-PYRIMIDINE INHIBITOR REMARK 900 RELATED ID: 4BCI RELATED DB: PDB REMARK 900 STRUCTURE OF CDK9 IN COMPLEX WITH CYCLIN T AND A 2 -AMINO-4- REMARK 900 HETEROARYL-PYRIMIDINE INHIBITOR REMARK 900 RELATED ID: 4BCJ RELATED DB: PDB REMARK 900 STRUCTURE OF CDK9 IN COMPLEX WITH CYCLIN T AND A 2 -AMINO-4- REMARK 900 HETEROARYL-PYRIMIDINE INHIBITOR REMARK 900 RELATED ID: 4BCK RELATED DB: PDB REMARK 900 STRUCTURE OF CDK2 IN COMPLEX WITH CYCLIN A AND A 2 -AMINO-4- REMARK 900 HETEROARYL-PYRIMIDINE INHIBITOR REMARK 900 RELATED ID: 4BCL RELATED DB: PDB REMARK 900 BACTERIOCHLOROPHYLL CONTAINING PROTEIN REMARK 900 RELATED ID: 4BCM RELATED DB: PDB REMARK 900 STRUCTURE OF CDK2 IN COMPLEX WITH CYCLIN A AND A 2 -AMINO-4- REMARK 900 HETEROARYL-PYRIMIDINE INHIBITOR REMARK 900 RELATED ID: 4BCN RELATED DB: PDB REMARK 900 STRUCTURE OF CDK2 IN COMPLEX WITH CYCLIN A AND A 2 -AMINO-4- REMARK 900 HETEROARYL-PYRIMIDINE INHIBITOR REMARK 900 RELATED ID: 4BCP RELATED DB: PDB REMARK 900 STRUCTURE OF CDK2 IN COMPLEX WITH CYCLIN A AND A 2 -AMINO-4- REMARK 900 HETEROARYL-PYRIMIDINE INHIBITOR REMARK 900 RELATED ID: 4BCQ RELATED DB: PDB REMARK 900 STRUCTURE OF CDK2 IN COMPLEX WITH CYCLIN A AND A 2 -AMINO-4- REMARK 900 HETEROARYL-PYRIMIDINE INHIBITOR REMARK 900 RELATED ID: 4BCR RELATED DB: PDB REMARK 900 STRUCTURE OF PPARALPHA IN COMPLEX WITH WY14643 REMARK 900 RELATED ID: 4ACM RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH 3-AMINO-6-(4-{[2-(DIMETHYLAMINO )ETHYL] REMARK 900 SULFAMOYL}-PHENYL)-N-PYRIDIN-3-YLPYRAZINE-2- CARBOXAMIDE DBREF 4BCO A 1 298 UNP P24941 CDK2_HUMAN 1 298 DBREF 4BCO B 171 432 UNP P30274 CCNA2_BOVIN 169 430 DBREF 4BCO C 1 298 UNP P24941 CDK2_HUMAN 1 298 DBREF 4BCO D 171 432 UNP P30274 CCNA2_BOVIN 169 430 SEQADV 4BCO GLY A -1 UNP P24941 EXPRESSION TAG SEQADV 4BCO SER A 0 UNP P24941 EXPRESSION TAG SEQADV 4BCO GLY C -1 UNP P24941 EXPRESSION TAG SEQADV 4BCO SER C 0 UNP P24941 EXPRESSION TAG SEQRES 1 A 300 GLY SER MET GLU ASN PHE GLN LYS VAL GLU LYS ILE GLY SEQRES 2 A 300 GLU GLY THR TYR GLY VAL VAL TYR LYS ALA ARG ASN LYS SEQRES 3 A 300 LEU THR GLY GLU VAL VAL ALA LEU LYS LYS ILE ARG LEU SEQRES 4 A 300 ASP THR GLU THR GLU GLY VAL PRO SER THR ALA ILE ARG SEQRES 5 A 300 GLU ILE SER LEU LEU LYS GLU LEU ASN HIS PRO ASN ILE SEQRES 6 A 300 VAL LYS LEU LEU ASP VAL ILE HIS THR GLU ASN LYS LEU SEQRES 7 A 300 TYR LEU VAL PHE GLU PHE LEU HIS GLN ASP LEU LYS LYS SEQRES 8 A 300 PHE MET ASP ALA SER ALA LEU THR GLY ILE PRO LEU PRO SEQRES 9 A 300 LEU ILE LYS SER TYR LEU PHE GLN LEU LEU GLN GLY LEU SEQRES 10 A 300 ALA PHE CYS HIS SER HIS ARG VAL LEU HIS ARG ASP LEU SEQRES 11 A 300 LYS PRO GLN ASN LEU LEU ILE ASN THR GLU GLY ALA ILE SEQRES 12 A 300 LYS LEU ALA ASP PHE GLY LEU ALA ARG ALA PHE GLY VAL SEQRES 13 A 300 PRO VAL ARG THR TYR TPO HIS GLU VAL VAL THR LEU TRP SEQRES 14 A 300 TYR ARG ALA PRO GLU ILE LEU LEU GLY CYS LYS TYR TYR SEQRES 15 A 300 SER THR ALA VAL ASP ILE TRP SER LEU GLY CYS ILE PHE SEQRES 16 A 300 ALA GLU MET VAL THR ARG ARG ALA LEU PHE PRO GLY ASP SEQRES 17 A 300 SER GLU ILE ASP GLN LEU PHE ARG ILE PHE ARG THR LEU SEQRES 18 A 300 GLY THR PRO ASP GLU VAL VAL TRP PRO GLY VAL THR SER SEQRES 19 A 300 MET PRO ASP TYR LYS PRO SER PHE PRO LYS TRP ALA ARG SEQRES 20 A 300 GLN ASP PHE SER LYS VAL VAL PRO PRO LEU ASP GLU ASP SEQRES 21 A 300 GLY ARG SER LEU LEU SER GLN MET LEU HIS TYR ASP PRO SEQRES 22 A 300 ASN LYS ARG ILE SER ALA LYS ALA ALA LEU ALA HIS PRO SEQRES 23 A 300 PHE PHE GLN ASP VAL THR LYS PRO VAL PRO HIS LEU ARG SEQRES 24 A 300 LEU SEQRES 1 B 262 SER VAL ASN GLU VAL PRO ASP TYR HIS GLU ASP ILE HIS SEQRES 2 B 262 THR TYR LEU ARG GLU MET GLU VAL LYS CYS LYS PRO LYS SEQRES 3 B 262 VAL GLY TYR MET LYS LYS GLN PRO ASP ILE THR ASN SER SEQRES 4 B 262 MET ARG ALA ILE LEU VAL ASP TRP LEU VAL GLU VAL GLY SEQRES 5 B 262 GLU GLU TYR LYS LEU GLN ASN GLU THR LEU HIS LEU ALA SEQRES 6 B 262 VAL ASN TYR ILE ASP ARG PHE LEU SER SER MET SER VAL SEQRES 7 B 262 LEU ARG GLY LYS LEU GLN LEU VAL GLY THR ALA ALA MET SEQRES 8 B 262 LEU LEU ALA SER LYS PHE GLU GLU ILE TYR PRO PRO GLU SEQRES 9 B 262 VAL ALA GLU PHE VAL TYR ILE THR ASP ASP THR TYR THR SEQRES 10 B 262 LYS LYS GLN VAL LEU ARG MET GLU HIS LEU VAL LEU LYS SEQRES 11 B 262 VAL LEU THR PHE ASP LEU ALA ALA PRO THR VAL ASN GLN SEQRES 12 B 262 PHE LEU THR GLN TYR PHE LEU HIS GLN GLN PRO ALA ASN SEQRES 13 B 262 CYS LYS VAL GLU SER LEU ALA MET PHE LEU GLY GLU LEU SEQRES 14 B 262 SER LEU ILE ASP ALA ASP PRO TYR LEU LYS TYR LEU PRO SEQRES 15 B 262 SER VAL ILE ALA ALA ALA ALA PHE HIS LEU ALA LEU TYR SEQRES 16 B 262 THR VAL THR GLY GLN SER TRP PRO GLU SER LEU ILE ARG SEQRES 17 B 262 LYS THR GLY TYR THR LEU GLU SER LEU LYS PRO CYS LEU SEQRES 18 B 262 MET ASP LEU HIS GLN THR TYR LEU LYS ALA PRO GLN HIS SEQRES 19 B 262 ALA GLN GLN SER ILE ARG GLU LYS TYR LYS ASN SER LYS SEQRES 20 B 262 TYR HIS GLY VAL SER LEU LEU ASN PRO PRO GLU THR LEU SEQRES 21 B 262 ASN LEU SEQRES 1 C 300 GLY SER MET GLU ASN PHE GLN LYS VAL GLU LYS ILE GLY SEQRES 2 C 300 GLU GLY THR TYR GLY VAL VAL TYR LYS ALA ARG ASN LYS SEQRES 3 C 300 LEU THR GLY GLU VAL VAL ALA LEU LYS LYS ILE ARG LEU SEQRES 4 C 300 ASP THR GLU THR GLU GLY VAL PRO SER THR ALA ILE ARG SEQRES 5 C 300 GLU ILE SER LEU LEU LYS GLU LEU ASN HIS PRO ASN ILE SEQRES 6 C 300 VAL LYS LEU LEU ASP VAL ILE HIS THR GLU ASN LYS LEU SEQRES 7 C 300 TYR LEU VAL PHE GLU PHE LEU HIS GLN ASP LEU LYS LYS SEQRES 8 C 300 PHE MET ASP ALA SER ALA LEU THR GLY ILE PRO LEU PRO SEQRES 9 C 300 LEU ILE LYS SER TYR LEU PHE GLN LEU LEU GLN GLY LEU SEQRES 10 C 300 ALA PHE CYS HIS SER HIS ARG VAL LEU HIS ARG ASP LEU SEQRES 11 C 300 LYS PRO GLN ASN LEU LEU ILE ASN THR GLU GLY ALA ILE SEQRES 12 C 300 LYS LEU ALA ASP PHE GLY LEU ALA ARG ALA PHE GLY VAL SEQRES 13 C 300 PRO VAL ARG THR TYR TPO HIS GLU VAL VAL THR LEU TRP SEQRES 14 C 300 TYR ARG ALA PRO GLU ILE LEU LEU GLY CYS LYS TYR TYR SEQRES 15 C 300 SER THR ALA VAL ASP ILE TRP SER LEU GLY CYS ILE PHE SEQRES 16 C 300 ALA GLU MET VAL THR ARG ARG ALA LEU PHE PRO GLY ASP SEQRES 17 C 300 SER GLU ILE ASP GLN LEU PHE ARG ILE PHE ARG THR LEU SEQRES 18 C 300 GLY THR PRO ASP GLU VAL VAL TRP PRO GLY VAL THR SER SEQRES 19 C 300 MET PRO ASP TYR LYS PRO SER PHE PRO LYS TRP ALA ARG SEQRES 20 C 300 GLN ASP PHE SER LYS VAL VAL PRO PRO LEU ASP GLU ASP SEQRES 21 C 300 GLY ARG SER LEU LEU SER GLN MET LEU HIS TYR ASP PRO SEQRES 22 C 300 ASN LYS ARG ILE SER ALA LYS ALA ALA LEU ALA HIS PRO SEQRES 23 C 300 PHE PHE GLN ASP VAL THR LYS PRO VAL PRO HIS LEU ARG SEQRES 24 C 300 LEU SEQRES 1 D 262 SER VAL ASN GLU VAL PRO ASP TYR HIS GLU ASP ILE HIS SEQRES 2 D 262 THR TYR LEU ARG GLU MET GLU VAL LYS CYS LYS PRO LYS SEQRES 3 D 262 VAL GLY TYR MET LYS LYS GLN PRO ASP ILE THR ASN SER SEQRES 4 D 262 MET ARG ALA ILE LEU VAL ASP TRP LEU VAL GLU VAL GLY SEQRES 5 D 262 GLU GLU TYR LYS LEU GLN ASN GLU THR LEU HIS LEU ALA SEQRES 6 D 262 VAL ASN TYR ILE ASP ARG PHE LEU SER SER MET SER VAL SEQRES 7 D 262 LEU ARG GLY LYS LEU GLN LEU VAL GLY THR ALA ALA MET SEQRES 8 D 262 LEU LEU ALA SER LYS PHE GLU GLU ILE TYR PRO PRO GLU SEQRES 9 D 262 VAL ALA GLU PHE VAL TYR ILE THR ASP ASP THR TYR THR SEQRES 10 D 262 LYS LYS GLN VAL LEU ARG MET GLU HIS LEU VAL LEU LYS SEQRES 11 D 262 VAL LEU THR PHE ASP LEU ALA ALA PRO THR VAL ASN GLN SEQRES 12 D 262 PHE LEU THR GLN TYR PHE LEU HIS GLN GLN PRO ALA ASN SEQRES 13 D 262 CYS LYS VAL GLU SER LEU ALA MET PHE LEU GLY GLU LEU SEQRES 14 D 262 SER LEU ILE ASP ALA ASP PRO TYR LEU LYS TYR LEU PRO SEQRES 15 D 262 SER VAL ILE ALA ALA ALA ALA PHE HIS LEU ALA LEU TYR SEQRES 16 D 262 THR VAL THR GLY GLN SER TRP PRO GLU SER LEU ILE ARG SEQRES 17 D 262 LYS THR GLY TYR THR LEU GLU SER LEU LYS PRO CYS LEU SEQRES 18 D 262 MET ASP LEU HIS GLN THR TYR LEU LYS ALA PRO GLN HIS SEQRES 19 D 262 ALA GLN GLN SER ILE ARG GLU LYS TYR LYS ASN SER LYS SEQRES 20 D 262 TYR HIS GLY VAL SER LEU LEU ASN PRO PRO GLU THR LEU SEQRES 21 D 262 ASN LEU MODRES 4BCO TPO A 160 THR PHOSPHOTHREONINE MODRES 4BCO TPO C 160 THR PHOSPHOTHREONINE HET TPO A 160 11 HET TPO C 160 11 HET T6Q A1299 33 HET SGM B1433 6 HET SGM B1434 6 HET SO4 B1435 5 HET T6Q C1298 33 HET SGM D1433 6 HET SGM D1434 6 HET SO4 D1435 5 HETNAM TPO PHOSPHOTHREONINE HETNAM T6Q 2-[[3-(4-ETHANOYL-1,4-DIAZEPAN-1-YL)PHENYL]AMINO]-4-[4- HETNAM 2 T6Q METHYL-2-(METHYLAMINO)-1,3-THIAZOL-5-YL]PYRIMIDINE-5- HETNAM 3 T6Q CARBONITRILE HETNAM SGM MONOTHIOGLYCEROL HETNAM SO4 SULFATE ION HETSYN TPO PHOSPHONOTHREONINE FORMUL 1 TPO 2(C4 H10 N O6 P) FORMUL 5 T6Q 2(C23 H26 N8 O S) FORMUL 6 SGM 4(C3 H8 O2 S) FORMUL 8 SO4 2(O4 S 2-) FORMUL 13 HOH *519(H2 O) HELIX 1 1 SER A 0 GLU A 2 5 3 HELIX 2 2 PRO A 45 LEU A 58 1 14 HELIX 3 3 LEU A 87 SER A 94 1 8 HELIX 4 4 PRO A 100 HIS A 121 1 22 HELIX 5 5 LYS A 129 GLN A 131 5 3 HELIX 6 6 THR A 165 ARG A 169 5 5 HELIX 7 7 ALA A 170 LEU A 175 1 6 HELIX 8 8 THR A 182 ARG A 199 1 18 HELIX 9 9 SER A 207 GLY A 220 1 14 HELIX 10 10 GLY A 229 MET A 233 5 5 HELIX 11 11 ASP A 247 VAL A 252 1 6 HELIX 12 12 ASP A 256 LEU A 267 1 12 HELIX 13 13 SER A 276 LEU A 281 1 6 HELIX 14 14 ALA A 282 GLN A 287 5 6 HELIX 15 15 TYR B 178 CYS B 193 1 16 HELIX 16 16 TYR B 199 GLN B 203 5 5 HELIX 17 17 THR B 207 TYR B 225 1 19 HELIX 18 18 GLN B 228 MET B 246 1 19 HELIX 19 19 LEU B 249 GLU B 269 1 21 HELIX 20 20 GLU B 274 THR B 282 1 9 HELIX 21 21 THR B 287 LEU B 302 1 16 HELIX 22 22 THR B 310 LEU B 320 1 11 HELIX 23 23 ASN B 326 ASP B 343 1 18 HELIX 24 24 ASP B 343 LEU B 348 1 6 HELIX 25 25 LEU B 351 THR B 368 1 18 HELIX 26 26 PRO B 373 GLY B 381 1 9 HELIX 27 27 THR B 383 ALA B 401 1 19 HELIX 28 28 PRO B 402 HIS B 404 5 3 HELIX 29 29 GLN B 407 TYR B 413 1 7 HELIX 30 30 LYS B 414 HIS B 419 5 6 HELIX 31 31 GLY B 420 LEU B 424 5 5 HELIX 32 32 PRO C 45 LEU C 58 1 14 HELIX 33 33 LEU C 87 SER C 94 1 8 HELIX 34 34 PRO C 100 HIS C 121 1 22 HELIX 35 35 LYS C 129 GLN C 131 5 3 HELIX 36 36 THR C 165 ARG C 169 5 5 HELIX 37 37 ALA C 170 LEU C 175 1 6 HELIX 38 38 THR C 182 ARG C 199 1 18 HELIX 39 39 SER C 207 GLY C 220 1 14 HELIX 40 40 ASP C 256 LEU C 267 1 12 HELIX 41 41 SER C 276 LEU C 281 1 6 HELIX 42 42 ALA C 282 GLN C 287 5 6 HELIX 43 43 TYR D 178 LYS D 194 1 17 HELIX 44 44 TYR D 199 GLN D 203 5 5 HELIX 45 45 THR D 207 TYR D 225 1 19 HELIX 46 46 GLN D 228 MET D 246 1 19 HELIX 47 47 LEU D 249 GLY D 251 5 3 HELIX 48 48 LYS D 252 GLU D 269 1 18 HELIX 49 49 GLU D 274 ILE D 281 1 8 HELIX 50 50 THR D 287 LEU D 302 1 16 HELIX 51 51 THR D 310 LEU D 320 1 11 HELIX 52 52 ASN D 326 ASP D 343 1 18 HELIX 53 53 ASP D 343 LEU D 348 1 6 HELIX 54 54 LEU D 351 GLY D 369 1 19 HELIX 55 55 PRO D 373 GLY D 381 1 9 HELIX 56 56 LEU D 387 ALA D 401 1 15 HELIX 57 57 PRO D 402 HIS D 404 5 3 HELIX 58 58 GLN D 407 TYR D 413 1 7 HELIX 59 59 LYS D 414 HIS D 419 5 6 HELIX 60 60 GLY D 420 LEU D 424 5 5 SHEET 1 AA 5 PHE A 4 GLU A 12 0 SHEET 2 AA 5 VAL A 17 ASN A 23 -1 O VAL A 18 N ILE A 10 SHEET 3 AA 5 VAL A 29 ARG A 36 -1 O VAL A 30 N ALA A 21 SHEET 4 AA 5 LYS A 75 GLU A 81 -1 O LEU A 76 N ILE A 35 SHEET 5 AA 5 LEU A 66 THR A 72 -1 N LEU A 67 O VAL A 79 SHEET 1 AB 3 GLN A 85 ASP A 86 0 SHEET 2 AB 3 LEU A 133 ILE A 135 -1 O ILE A 135 N GLN A 85 SHEET 3 AB 3 ILE A 141 LEU A 143 -1 O LYS A 142 N LEU A 134 SHEET 1 AC 2 VAL A 123 LEU A 124 0 SHEET 2 AC 2 ARG A 150 ALA A 151 -1 O ARG A 150 N LEU A 124 SHEET 1 CA 5 PHE C 4 GLY C 11 0 SHEET 2 CA 5 VAL C 17 ASN C 23 -1 O VAL C 18 N ILE C 10 SHEET 3 CA 5 VAL C 29 ARG C 36 -1 O VAL C 30 N ALA C 21 SHEET 4 CA 5 LYS C 75 GLU C 81 -1 O LEU C 76 N ILE C 35 SHEET 5 CA 5 LEU C 66 ILE C 70 -1 N LEU C 67 O VAL C 79 SHEET 1 CB 3 GLN C 85 ASP C 86 0 SHEET 2 CB 3 LEU C 133 ILE C 135 -1 O ILE C 135 N GLN C 85 SHEET 3 CB 3 ILE C 141 LEU C 143 -1 O LYS C 142 N LEU C 134 SHEET 1 CC 2 VAL C 123 LEU C 124 0 SHEET 2 CC 2 ARG C 150 ALA C 151 -1 O ARG C 150 N LEU C 124 LINK C TYR A 159 N TPO A 160 1555 1555 1.33 LINK C TPO A 160 N HIS A 161 1555 1555 1.33 LINK SG CYS B 193 S1 SGM B1434 1555 1555 1.94 LINK C TYR C 159 N TPO C 160 1555 1555 1.33 LINK C TPO C 160 N HIS C 161 1555 1555 1.33 CISPEP 1 GLU A 40 THR A 41 0 9.30 CISPEP 2 VAL A 154 PRO A 155 0 -5.65 CISPEP 3 GLN B 323 PRO B 324 0 -4.99 CISPEP 4 ASP B 345 PRO B 346 0 9.75 CISPEP 5 VAL C 154 PRO C 155 0 0.23 CISPEP 6 GLN D 323 PRO D 324 0 -1.56 CISPEP 7 ASP D 345 PRO D 346 0 10.01 SITE 1 AC1 16 GLU A 8 GLY A 13 LYS A 20 ALA A 31 SITE 2 AC1 16 VAL A 64 PHE A 80 GLU A 81 PHE A 82 SITE 3 AC1 16 LEU A 83 HIS A 84 GLN A 85 LYS A 89 SITE 4 AC1 16 ASN A 132 LEU A 134 ASP A 145 HOH A2039 SITE 1 AC2 15 GLU C 8 GLY C 13 VAL C 18 VAL C 64 SITE 2 AC2 15 PHE C 80 GLU C 81 PHE C 82 LEU C 83 SITE 3 AC2 15 HIS C 84 ASP C 86 ASN C 132 LEU C 134 SITE 4 AC2 15 ASP C 145 HOH C2056 GLN D 403 SITE 1 AC3 2 CYS B 327 GLU B 330 SITE 1 AC4 7 HOH A2048 MET B 189 LYS B 192 CYS B 193 SITE 2 AC4 7 ARG B 241 ASP B 305 HOH B2092 SITE 1 AC5 6 MET D 189 LYS D 192 CYS D 193 ARG D 241 SITE 2 AC5 6 ASP D 305 ALA D 308 SITE 1 AC6 3 ASN D 326 CYS D 327 GLU D 330 SITE 1 AC7 8 LYS B 202 GLN B 203 LEU B 243 SER B 244 SITE 2 AC7 8 SER B 245 MET B 246 SER B 247 HOH B2072 SITE 1 AC8 6 LYS A 65 LYS D 202 LEU D 243 SER D 245 SITE 2 AC8 6 MET D 246 SER D 247 CRYST1 73.902 133.813 148.382 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013531 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007473 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006739 0.00000